Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹3 Cr
Revenue (TTM)
₹3 Cr
Net Profit (TTM)
₹-333 Cr
ROE
-451.8 %
ROCE
-12.7 %
P/E Ratio
0
P/B Ratio
-0
Industry P/E
44.74
EV/EBITDA
-40.9
Div. Yield
0 %
Debt to Equity
-37
Book Value
₹--
EPS
₹12.8
Face value
1
Shares outstanding
202,752,380
CFO
₹833.42 Cr
EBITDA
₹374.53 Cr
Net Profit
₹-312.98 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Surya Pharmaceutical
| -23.8 | -20.0 | -11.1 | -87.6 | -53.0 | -64.5 | -36.7 |
|
BSE Sensex*
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
BSE Healthcare#
| -4.7 | -5.8 | -5.4 | 1.3 | 23.7 | 14.0 | 10.6 |
|
Company
|
2014
|
|---|---|
|
Surya Pharmaceutical
| -83.7 |
|
BSE Sensex
| 29.9 |
|
BSE Healthcare
| 47.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Surya Pharmaceutical
|
0.2 | 3.2 | 2.6 | 258.7 | -2,984.6 | -- | 0 | 0.0 |
| 2,110.2 | 17,282.6 | 1,215.1 | 284.8 | 28.7 | 21.1 | 60.2 | 11.4 | |
| 656.2 | 12,893.6 | 7,266.8 | 627.5 | 11.9 | 12.6 | 20.5 | 2.4 | |
| 613.6 | 15,214.7 | 5,092.5 | 545.5 | 15.9 | 14.1 | 27.9 | 3.7 | |
| 839.3 | 13,375.6 | 7,918.4 | 429.9 | 10.7 | 7.2 | 30.9 | 2.0 | |
| 1,027.6 | 18,409.8 | 4,560.2 | 1,544.6 | 35.1 | 19.2 | 11.8 | 2.1 | |
| 1,404.5 | 16,092.2 | 1,419.3 | 20.1 | 8.4 | 0.5 | 800.5 | 2.8 | |
| 142.2 | 18,882.0 | 8,871.4 | -223.5 | 1.9 | -1.6 | -- | 2.4 | |
| 391.1 | 15,752.9 | 3,720.2 | 352.1 | 13.7 | 8.2 | 44.7 | 3.3 | |
| 1,271.5 | 20,670.6 | 3,151.0 | -10.0 | 8.4 | 2.5 | 939.6 | 4.5 |
No Review & Analysis are available.
Manufacture of allopathic pharmaceutical preparations
Incorporated
1992
Chairman
Rajiv Goyal
Managing Director
Rajiv Goyal
Headquarters
New Delhi, New Delhi
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsShareholding Pattern for September 30, 2015
21-Oct-2015Shareholding Pattern For June 30, 2015
22-Jul-2015Shareholding Pattern For March 31, 2015
21-Apr-2015Shareholding Pattern For December 31, 2014
20-Jan-2015
The share price of Surya Pharmaceutical Ltd is ₹0.16 (BSE) and ₹1.30 (NSE) as of 14-Sep-2015 IST. Surya Pharmaceutical Ltd has given a return of -52.99% in the last 3 years.
The P/E ratio of Surya Pharmaceutical Ltd is 0.01 times as on 14-Sep-2015, a 100 discount to its peers’ median range of 44.74 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2013
|
0.00
|
-0.35
|
|
2012
|
0.00
|
1.18
|
|
2011
|
5.80
|
1.06
|
|
2010
|
0.38
|
0.93
|
|
2009
|
0.14
|
0.34
|
The 52-week high and low of Surya Pharmaceutical Ltd are Rs -- and Rs -- as of 03-Apr-2026.
Surya Pharmaceutical Ltd has a market capitalisation of ₹ 3 Cr as on 14-Sep-2015. As per SEBI classification, it is a company.
Before investing in Surya Pharmaceutical Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹-0.01
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.